Graham Walmsley is an Investment Professional at Versant Ventures focused on biotechnology and healthcare investments. Graham joined Versant after completing his training as a Physician Scientist Fellow at Stanford University School of Medicine. During his medical training, Graham served as a subintern in the Division of Plastic & Reconstructive Surgery at Stanford Hospital and Brigham and Women’s Hospital in Boston. As a Bio-X Fellow and Thermo Scientific Pierce Scholar, Graham conducted his thesis work in the laboratories of Irving Weissman and Michael Longaker with a focus on regenerative medicine, stem cells and therapeutic approaches to fibrosis. Graham’s work was featured in TIME Magazine and resulted in several international patents as well as over 60 peer-reviewed publications in journals such as Science and Cell.
Graham received his M.D. and Ph.D. in Stem Cell Biology and Regenerative Medicine from Stanford University. Graham earned his B.A. in Molecular and Cell Biology with summa cum laude honors from the University of California, Berkeley.